Impact Biomedical Quote - IBO

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.50

Bid

Offer

Volume

39,787

1.43 Day's Range 1.8264

1.16 52 Week Range 3.25

Previous Close

1.60

Open

1.53

Last Trade

100

1.4394

Last Trade Time

Average Volume (3m)

52,843

Financial Volume

US$ 61,221

VWAP

1.5387

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

Form 8-K - Current report

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

Form 8-K - Current report

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.12	-7.40740740741	1.62	1.67	1.16	42423	1.34641389	CS
4	-1.33	-46.9964664311	2.83	2.95	1.16	37600	1.90390172	CS
12	-0.1	-6.25	1.6	3.25	1.16	52843	2.14248913	CS
26	-1.5	-50	3	3.25	1.16	78929	2.24944644	CS
52	-1.5	-50	3	3.25	1.16	78929	2.24944644	CS
156	-1.5	-50	3	3.25	1.16	78929	2.24944644	CS
260	-1.5	-50	3	3.25	1.16	78929	2.24944644	CS

IBO - Frequently Asked Questions (FAQ)

What is the current Impact Biomedical share price?

The current share price of Impact Biomedical is US$ 1.50

What is the 1 year trading range for Impact Biomedical share price?

Impact Biomedical has traded in the range of US$ 1.16 to US$ 3.25 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRFXGraphex Group Limited	US$ 0.435 (52.33%)	9.1M
WWRWestwater Resources Inc	US$ 0.85 (46.55%)	8.04M
RYDERyde Group Ltd	US$ 0.6298 (42.81%)	5.98M
AMBOAmbow Education Holding Ltd	US$ 3.09 (37.95%)	6.54M
BURUNuburu Inc	US$ 0.5857 (32.21%)	10.04M
USEUSCF Energy Commodity Strategy Absolute Return Fund	US$ 27.40 (-27.89%)	2.17k
ROLRHigh Roller Technologies Inc	US$ 4.02 (-21.02%)	53.42k
MMAMixed Martial Arts Group Limited	US$ 1.441 (-17.66%)	132.1k
CPHIChina Pharma Holdings Inc	US$ 0.176 (-15.79%)	2.5M
HTUSCapitol Series Trust	US$ 38.80 (-15.15%)	50.61k
UVIX2x Long VIX Futures ETF	US$ 3.215 (8.25%)	91.49M
OPTTOcean Power Technologies Inc	US$ 0.4711 (3.97%)	81.92M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6.00 (3.27%)	81.61M
KULRKULR Technology Group Inc	US$ 4.66 (-2.92%)	77.49M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.195 (10.03%)	65.17M